Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows provided by (used in) operating activities:
Net earnings	$ 665.1	$ 605.4
Adjustments to reconcile net earnings to cash provided by operating activities:
Depreciation and amortization	732.7	710.5
Share-based compensation	79.9	74.5
Changes in operating assets and liabilities, net of acquired assets and liabilities
Income taxes	(181.2)	23.4
Receivables	(40.1)	15.5
Inventories	(38.0)	(212.2)
Accounts payable and accrued liabilities	(204.7)	(219.5)
Other assets and liabilities	(20.5)	(4.5)
Net cash provided by operating activities	993.1	993.2
Cash flows provided by (used in) investing activities:
Additions to instruments	(188.4)	(232.8)
Additions to other property, plant and equipment	(152.3)	(228.3)
Net investment hedge settlements	19.3	27.2
Business combination investments, net of acquired cash	(116.3)	(32.9)
Acquisition of intangible assets	(119.6)	(98.4)
Other investing activities	(39.7)	7.0
Net cash used in investing activities	(596.9)	(558.1)
Cash flows provided by (used in) financing activities:
Net payments on revolving facilities	(50.0)	(20.0)
Proceeds from senior notes	700.0	0.0
Redemption of senior notes	0.0	(86.3)
Payment on term loan	0.0	(33.9)
Dividends paid to stockholders	(148.0)	(150.7)
Proceeds from employee stock compensation plans	81.6	81.8
Business combination contingent consideration payments	(3.5)	(10.3)
Deferred business combination payments	(8.8)	(4.0)
Repurchase of common stock	(795.8)	(281.9)
Other financing activities	(19.4)	(6.8)
Net cash used in financing activities	(243.9)	(512.1)
Effect of exchange rates on cash and cash equivalents	1.0	(6.5)
Change in cash and cash equivalents	153.3	(83.5)
Cash and cash equivalents, beginning of year	415.8	375.7
Cash and cash equivalents, end of period	$ 569.0	$ 292.1